4:18 PM ET
8-K
Other 8-K Filing
Pyxis Oncology Other 8-K Filing
Pyxis Oncology stockholders approved an amendment to the company's Certificate of Incorporation to double the number of authorized shares of common stock from 190 million to 380 million. The amendment became effective upon filing with the Secretary of State of Delaware on November 13, 2026. No shares were issued or sold as part of this filing, which primarily serves to reserve capacity for future corporate purposes.